Chinese Medical Device Provider Blue Sail Picks Up 10.16% Stake In Artificial Heart Developer

This Data Is Locked!

This area is available only to Subscribers.

Blue Sail announced on Wednesday that the company and some of its executives have paid RMB101.60 million (US$14.71 million) for a 10.16% stake in Tongxin... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?